Cargando…

Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study

BACKGROUND: (Es)ketamine and monoamine oxidase inhibitors (MAOIs), e.g., tranylcypromine, are therapeutic options for treatment-resistant major depression. Simultaneous administration is currently not recommended because of concern about hypertensive crises. OBJECTIVE: Our objective was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludwig, Vera M., Sauer, Cathrin, Young, Allan H., Rucker, James, Bauer, Michael, Findeis, Hannelore, Ritter, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354966/ https://www.ncbi.nlm.nih.gov/pubmed/34283390 http://dx.doi.org/10.1007/s40263-021-00837-6

Ejemplares similares

Urothelial toxicity of esketamine in the treatment of depression
por: Findeis, Hannelore, et al.
Publicado: (2020)

The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD
por: Park, HyunHee, et al.
Publicado: (2020)

USE OF TRANYLCYPROMINE IN SEVERE RESISTANT DEPRESSION : A CASE REPORT
por: Maulik, Pallab K., et al.
Publicado: (1999)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
por: Del Sant, Lorena Catarina, et al.
Publicado: (2022)

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts
por: Akinci, Melek, et al.
Publicado: (2019)

Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
por: Kavakbasi, E., et al.
Publicado: (2022)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Esketamine hydrochloride for treatment-resistant depression
Publicado: (2021)

Tranylcypromine specificity for monoamine oxidase is limited by promiscuous protein labelling and lysosomal trapping
por: Drechsel, Jonas, et al.
Publicado: (2020)

Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity
por: Fioravanti, Rossella, et al.
Publicado: (2022)

A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
por: Magalhães, Eduardo Jorge Muniz, et al.
Publicado: (2021)

Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D(3) Receptor Antagonists
por: Chen, Jianyong, et al.
Publicado: (2014)

Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Maó
por: Quintana, Josep M. (Josep Maria)
Publicado: (1996)

Comparison of Subjective and Objective Sleep Estimations in Patients with Bipolar Disorder and Healthy Control Subjects
por: Ritter, Philipp S., et al.
Publicado: (2016)

Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells
por: LEE, HYUNG TAE, et al.
Publicado: (2013)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
por: Finberg, John P. M., et al.
Publicado: (2016)

Mao : a biography /
por: Terrill, Ross
Publicado: (1981)

EFFECT OF IMIPRAMINE AND ECT ON PLATELET MAO ACTIVITY IN DEPRESSIVES
por: Trivedi, J.K., et al.
Publicado: (1989)

Mao Zedong
por: Grimm, Tilemann
Publicado: (1986)

The Clinical Application of Remimazolam Benzenesulfonate Combined with Esketamine Intravenous Anesthesia in Endoscopic Retrograde Cholangiopancreatography
por: Yi, Xiuna, et al.
Publicado: (2022)

Opioid Free Total Intravenous Anesthesia With Dexmedetomidine-Esketamine-Lidocaine for Patients Undergoing Lumpectomy
por: Qian, Xia Li, et al.
Publicado: (2023)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
por: Pepe, Maria, et al.
Publicado: (2023)

Individual and Combined Effect of MAO-A/MAO-B Gene Variants and Adverse Childhood Experiences on the Severity of Major Depressive Disorder
por: Toledo-Lozano, Christian Gabriel, et al.
Publicado: (2023)

Serotonin Syndrome Masquerading as Status Epilepticus following Ingestion of Tranylcypromine and Clomipramine and L-Tryptophan: A Case Report
por: Ambarapu, Swetha, et al.
Publicado: (2022)

Mao Tse-Tung
por: Payne, Robert
Publicado: (1972)

Mao Tse-tung
por: MacGregor-hastie, Roy

Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
por: Rognoni, Carla, et al.
Publicado: (2023)

Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
por: Vasiliu, Octavian
Publicado: (2023)

Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
por: Faisant, S., et al.
Publicado: (2022)

Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode
por: Basto, M. D. R. D. R. F. D. A., et al.
Publicado: (2023)

Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
por: Hagenow, Jens, et al.
Publicado: (2020)

Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial
por: Ling, Bin, et al.
Publicado: (2023)

Behavioral Alterations in Response to Fear-Provoking Stimuli and Tranylcypromine Induced by Perinatal Exposure to Bisphenol A and Nonylphenol in Male Rats
por: Negishi, Takayuki, et al.
Publicado: (2004)

Is (S)-norketamine an alternative antidepressant for esketamine?
por: Hashimoto, Kenji, et al.
Publicado: (2018)

Changes of MAO-A and MAO-B Expressions in the Placenta of MPTP or MPP(+) Treated Mice
por: Sai, Takafumi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_66751c6svgrhfkc0ghk06027sn